Marinomed Biotech AG
Develops treatments for viral infectious diseases and immunological disorders.
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Manufacturing
Description
Marinomed Biotech AG is a biopharmaceutical company that develops medicinal products and medical devices for viral infectious diseases and immunological disorders. The company's innovation is driven by proprietary, patent-protected technology platforms. The Marinosolv platform enhances the solubility and bioavailability of poorly soluble compounds, enabling the development of treatments for immunological conditions such as allergies, asthma, and inflammatory diseases. The virology platform is the basis for therapies targeting viral respiratory infections. Marinomed maintains a development pipeline, has globally marketed therapeutics, and offers its technology through partnerships and services via its Solv4U unit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-04-19 07:45 |
Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook…
|
English | 18.0 KB | ||
| 2023-04-12 07:45 |
Marinomed Biotech AG publishes clinical data on the effectiveness of its Carr…
|
English | 13.0 KB | ||
| 2023-03-31 10:00 | English | 6.3 KB | |||
| 2023-03-31 10:00 | German | 6.3 KB | |||
| 2023-03-14 07:45 |
Marinomed Biotech AG reports positive clinical data for the Carragelose deconge…
|
English | 13.3 KB | ||
| 2023-02-16 07:45 |
Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit g…
|
English | 11.2 KB | ||
| 2023-02-14 14:00 | English | 8.1 KB | |||
| 2023-02-14 14:00 | German | 8.1 KB | |||
| 2023-01-31 10:00 | English | 6.3 KB | |||
| 2023-01-31 10:00 | German | 6.3 KB | |||
| 2022-12-27 07:45 |
Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Mar…
|
English | 15.8 KB | ||
| 2022-11-21 07:45 |
Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 a…
|
English | 22.4 KB | ||
| 2022-10-20 07:45 |
First successful year on the market for Marinomeds Solv4U technology partnershi…
|
English | 16.3 KB | ||
| 2022-09-20 13:33 | German | 81.0 KB | |||
| 2022-09-20 13:33 | English | 80.7 KB |
Automate Your Workflow. Get a real-time feed of all Marinomed Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Marinomed Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Marinomed Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
